Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Hon

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
American Heart Journal|November 22, 2001
Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failureM K Al-Obaidi, J K Hon, P J Stubbs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2012
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerM A Socinski, C J Langer, I Okamoto, et al.
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
Cancer|April 3, 1999
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaJ D Hainsworth, H A Burris, J B Erland, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
American Heart Journal|November 22, 2001
Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failureM K Al-Obaidi, J K Hon, P J Stubbs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2012
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerM A Socinski, C J Langer, I Okamoto, et al.
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
Cancer|April 3, 1999
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaJ D Hainsworth, H A Burris, J B Erland, et al.
Pageof 2